Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
  • Article usage
  • Citations to this article

Advertisement

Research Article Free access | 10.1172/JCI105749

Absorption of hemoglobin iron: the role of a heme-splitting substance in the intestinal mucosa

Lewis R. Weintraub, Morton B. Weinstein, Hans-Jurg Huser, and Sheila Rafal

Department of Hematology and the Blood Research Laboratory, Tufts University School of Medicine-New England Medical Center Hospitals, Boston, Massachusetts

Find articles by Weintraub, L. in: JCI | PubMed | Google Scholar

Department of Hematology and the Blood Research Laboratory, Tufts University School of Medicine-New England Medical Center Hospitals, Boston, Massachusetts

Find articles by Weinstein, M. in: JCI | PubMed | Google Scholar

Department of Hematology and the Blood Research Laboratory, Tufts University School of Medicine-New England Medical Center Hospitals, Boston, Massachusetts

Find articles by Huser, H. in: JCI | PubMed | Google Scholar

Department of Hematology and the Blood Research Laboratory, Tufts University School of Medicine-New England Medical Center Hospitals, Boston, Massachusetts

Find articles by Rafal, S. in: JCI | PubMed | Google Scholar

Published March 1, 1968 - More info

Published in Volume 47, Issue 3 on March 1, 1968
J Clin Invest. 1968;47(3):531–539. https://doi.org/10.1172/JCI105749.
© 1968 The American Society for Clinical Investigation
Published March 1, 1968 - Version history
View PDF
Abstract

The dog behaves like man in his ability to utilize dietary hemoglobin iron and, therefore, is an excellent model in which to study the mechanisms of absorption. Heme is taken up intact into the epithelial cell of the small intestine but the iron appears in the plasma in a nonheme form. A substance is present in mucosal homogenates which is capable of releasing iron from a hemoglobin substrate in vitro. This has a molecular weight greater than 64,000, and appears to behave as an enzyme. There is no difference in the in vitro, effective concentration of the hemesplitting substance in the mucosa of iron-loaded and iron-deficient dogs to explain in vivo changes in iron absorption. However, the rate at which the heme-splitting substance works in vivo appears to be increased by the removal of the nonheme-iron-end product from the epithelial cell to the plasma. Reduction of the heme-iron content within the epithelial cell may then enhance uptake from the lumen. These studies suggest that the labile nonheme-iron content of the intestinal epithelial cell determines its ability to accept heme as well as ionized iron from the lumen.

Browse pages

Click on an image below to see the page. View PDF of the complete article

icon of scanned page 531
page 531
icon of scanned page 532
page 532
icon of scanned page 533
page 533
icon of scanned page 534
page 534
icon of scanned page 535
page 535
icon of scanned page 536
page 536
icon of scanned page 537
page 537
icon of scanned page 538
page 538
icon of scanned page 539
page 539
Version history
  • Version 1 (March 1, 1968): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts